‘The raising would see Keypath list with a $817.2 million market capitalisation on a fully diluted basis and a $772.3 million enterprise value.The deal valued Keypath at 5.8-times FY21 forecast revenue and 4.5-times FY22 revenue, according to terms sent to fund managers earlier in the marketing program.’
